References
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020
P. Pujol, J.P. Daures, N. Nsakala, L. Baldet, J. Bringer, C. Jaffiol, Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 81(12), 4318–4323 (1996). https://doi.org/10.1210/jcem.81.12.8954034
D.S. Cooper, B. Specker, M. Ho, M. Sperling, P.W. Ladenson, D.S. Ross, K.B. Ain, S.T. Bigos, J.D. Brierley, B.R. Haugen, I. Klein, J. Robbins, S.I. Sherman, T. Taylor, H.R. Maxon 3rd, Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8(9), 737–744 (1998) https://doi.org/10.1089/thy.1998.8.737
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iñiguez-Ariza, N.M., Stan, M.N. & Bible, K.C. Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer. Endocrine 59, 228–229 (2018). https://doi.org/10.1007/s12020-017-1464-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1464-5